Advancing our innovative pipeline
to address unmet needs

Selected Publications

TransCon Growth Hormone

A Randomized Phase 2 Study of Long-Acting TransCon Growth Hormone vs. Daily GH in Childhood GH Deficiency
P. Chatelain, O. Malievsky, K. Radziuk, G. Senatorova, M. Abdou, E. Vlachopapadopolou, Y. Skorodok, V. Peterkova, J. Leff, M. Beckert, the TransCon GH Working Group. JCEM. 2017. jc.2016-3776. doi: 10.1210/jc.2016-3776.

A Phase 2 Trial of Long-acting TransCon Growth Hormone in Adult GH Deficiency
C. Höybye, A. Pfeiffer, D. Ferone, J. Christiansen, D. Gilfoyle, E. Christoffersen, E. Mortensen, J. Leff and M. Beckert. Endocr Connect. 2017. EC-17-0007.

Pediatric Phase 2 Data Demonstrate That TransCon hGH Has an Anti-hGH Immunogenic Profile That Is Comparable to Daily hGH
D. Gilfoyle, S. Pihl, P. Chatelain, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

A Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Prepubertal Children with Growth Hormone Deficiency (GHD)
P. Chatelain, O. Malievsky, K. Radziuk, G. Senatorova, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Design and Clinical Development of TransCon Growth Hormone for Growth Hormone Deficiency
M. Beckert, D. Gilfoyle, J.M. Mikkelsen, et al. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Pharmacokinetic Modelling Predicts Native hGH Levels Following Administration of a Sustained-release Prodrug, TransCon hGH, to Children With GHD
K. Sprogøe, M. Beckert, E.D. Christoffersen, D. Gilfoyle, T. Wegge. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).